Companies: 10,795·Total market cap: $144.5T
Biodesix, Inc.

Biodesix, Inc.

BDSXNASDAQHealthcare● Active
$14.95
$-0.51(-3.30%)
Market Cap$121697171
P/E Ratio
52W High$20.21
52W Low$5

Biodesix, Inc.(BDSX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BDSX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$88.50M$71.32M$49.09M$38.21M$54.51M
Cost of Revenue$16.72M$15.57M$13.01M$14.15M$30.52M
Gross Profit$71.78M$55.75M$36.08M$24.06M$23.99M
Gross Margin %(computed)81.11%78.17%73.50%62.96%44.01%
Operating Expenses
R&D Expenses$12.00M$9.56M$9.99M$13.10M$12.79M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses$99.55M$90.25M$77.42M$74.64M$64.93M
Operating Income($27.77M)($34.50M)($41.34M)($50.59M)($40.94M)
Operating Margin %(computed)-31.37%-48.37%-84.22%-132.39%-75.11%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$7.72M$8.26M$9.54M$8.07M$4.51M
Income Before Tax($35.27M)($42.93M)($52.15M)($65.45M)($43.16M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($35.27M)($42.93M)($52.15M)($65.45M)($43.16M)
Net Margin %(computed)-39.85%-60.19%-106.23%-171.27%-79.18%
Per Share & EBITDA
EPS (Basic)$-4.67$-6.60$-12.80$-31.00$-31.60
Wtd Avg Shares7.55M6.48M4.11M2.11M1.37M
EBITDA($21.95M)($29.22M)($37.10M)($51.53M)($35.47M)
EBITDA Margin %(computed)-24.80%-40.96%-75.59%-134.86%-65.08%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Biodesix, Inc.

关于Biodesix, Inc.(BDSX)损益表

Biodesix, Inc.(BDSX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BDSX实现营收$0.09B,毛利润$0.07B(毛利率81.11%),净利润($0.04B)(净利率-39.85%)。

常见问题

BDSX · 4 问

Biodesix, Inc.(BDSX)2025财年营收为$0.09B,同比up24.1%。

BDSX revenueBDSX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09